A call to manufacturers to submit Stability data of non-patent and proprietary medicines from DCGI

  • News
  • September 2, 2017

The Drugs Controller General of India (DCGI) asks manufacturers to submit stability data, as this is important to ensure the quality, safety, and efficacy of the drugs throughout its shelf life. Drug manufacturers will get permission to manufacture drugs based on their stability data reports.

All state/UT drugs controllers have directed pharma companies to submit stability data to ensure drugs are meeting quality standards and are effective until their expiry date.The DCGI has also asked to submit self-assessment report of their units along with self-certification. Self-declaration should state that they are complying with GMP/GLP requirement as per Drugs and Cosmetic Rules, to the State Licensing Authorities and CDSCO by 30.08.2017.

To regulate import, manufacture, and distribution of the drugs, there is an act passed in 1940, called the Drugs & Cosmetics Act and in 1945, one more act

made under the Act prescribe statutory requirements for a grant of a license to manufacture for sale and distribution of drugs to ensure safety, efficacy, and quality of drugs manufactured and sold in the country called The Drugs & Cosmetics Rules.

The manufacturers should ensure that they are following best practices and guidelines to the licensing authority, evidence and data justifying that the medicines are stable under the condition of storage recommended getting licenses for non-patent and proprietary medicines.

A detailed checklist prepared by the DCGI office earlier to check all manufacturing facilities comply with the requirements of Good Manufacturing Practices (GMP) and Good Laboratory Practices (GLP) as specified under Schedule M and Schedule L-1 of the Drugs and Cosmetics Act and Rules there under. This list will guarantee that each manufacturer carries out self-assessment to GMP/GLP compliance.

  • Related Posts

    ‘A Knight in Shining Armor’ packed a punch in FOGSI for Gender Equality

    New Delhi: There was no fog in sight; FOGSI was shining as never before, thanks to the leadership of its outgoing president Dr Hrishikesh Pai. The over 40, 000 strong…

    • News
    • December 16, 2023
    • 7 views
    Women are on Trajectory to make Presence Felt in Healthcare India

    New Delhi: It could be advantage patients in times to come as women as workforce are increasing in healthcare domain of India. It is given that women power blended with…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Spurious drugs: Maiden Pharma blacklisted, all contracts cancelled

    Spurious drugs: Maiden Pharma blacklisted, all contracts cancelled

    DCC Calls For Strict Implementation Of Revised Schedule M, State-Level Activities To Address AMR

    DCC Calls For Strict Implementation Of Revised Schedule M, State-Level Activities To Address AMR

    Sanofi, Cipla Join Hands To Expand Reach Of CNS Portfolio In India

    Sanofi, Cipla Join Hands To Expand Reach Of CNS Portfolio In India

    Cyberabad Police Seize 1 Kg Alprazolam, Arrest Three

    Cyberabad Police Seize 1 Kg Alprazolam, Arrest Three

    Lee Health develops natural capsule for effective Heart care

    Lee Health develops natural capsule for effective Heart care

    Medical Shop Run By Twenty20 In Kizhakkambalam Asked To Shut Down

    Medical Shop Run By Twenty20 In Kizhakkambalam Asked To Shut Down